Effect of antidepressant treatment on platelet 5-HT content and relation to therapeutic outcome in unipolar depressive patients
- 1 November 1991
- journal article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 23 (3), 157-164
- https://doi.org/10.1016/0165-0327(91)90028-q
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- The effects of chronic trimipramine treatment on biogenic amine metabolism and on dopamine D2, 5-HT2 and tryptamine binding sites in rat brainGeneral Pharmacology: The Vascular System, 1990
- Do imipramine and dihydroergosine possess two components - one stimulating 5-HT1 and the other inhibiting 5-HT2 receptors?Life Sciences, 1990
- Increased serotonin2 (5-HT2) receptor binding as measured by 3H-lysergic acid diethylamide (3H-LSD) in the blood platelets of depressed patientsLife Sciences, 1989
- FluvoxamineDrugs, 1986
- Current AntidepressantsAnnual Review of Pharmacology and Toxicology, 1986
- Comparison between a serotonin and a noradrenaline reuptake blocker in the treatment of depressed outpatients Biochemical aspectsActa Psychiatrica Scandinavica, 1986
- Reduced Vmax of 3H-serotonin uptake but unchanged 3H-imipramine binding in the platelets of untreated hypertensive subjectsLife Sciences, 1984
- Reduced uptake of serotonin but unchanged 3H-imipramine binding in the platelets from cirrhotic patientsLife Sciences, 1981
- The content and uptake of 5-HT by blood platelets in depressive patientsJournal of Neural Transmission, 1979
- Effects of tricyclic antidepressants upon human platelet monoamine oxidaseLife Sciences, 1974